EUR 22.9
(0.44%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.5 Billion EUR | -0.39% |
2022 | 1.51 Billion EUR | -1.09% |
2021 | 1.52 Billion EUR | 2.19% |
2020 | 1.49 Billion EUR | 22.61% |
2019 | 1.22 Billion EUR | 68.94% |
2018 | 722.73 Million EUR | -0.07% |
2017 | 723.27 Million EUR | 8.21% |
2016 | 668.41 Million EUR | 5.8% |
2015 | 631.76 Million EUR | 8.12% |
2014 | 584.29 Million EUR | 16.36% |
2013 | 502.14 Million EUR | 18.45% |
2012 | 423.91 Million EUR | 22.57% |
2011 | 345.86 Million EUR | 28.83% |
2010 | 268.47 Million EUR | 6.72% |
2009 | 251.56 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.54 Billion EUR | 0.0% |
2023 FY | 1.5 Billion EUR | -0.39% |
2023 Q4 | 1.5 Billion EUR | 0.0% |
2023 Q2 | 1.55 Billion EUR | 0.0% |
2022 Q2 | 1.54 Billion EUR | 0.0% |
2022 FY | 1.51 Billion EUR | -1.09% |
2022 Q4 | 1.51 Billion EUR | 0.0% |
2021 FY | 1.52 Billion EUR | 2.19% |
2021 Q4 | 1.52 Billion EUR | 0.0% |
2021 Q2 | 1.48 Billion EUR | 0.0% |
2020 Q4 | 1.49 Billion EUR | 0.0% |
2020 Q2 | 1.23 Billion EUR | 0.0% |
2020 FY | 1.49 Billion EUR | 22.61% |
2019 FY | 1.22 Billion EUR | 68.94% |
2019 Q2 | 1.18 Billion EUR | 0.0% |
2019 Q4 | 1.22 Billion EUR | 0.0% |
2018 FY | 722.73 Million EUR | -0.07% |
2018 Q4 | 722.73 Million EUR | 0.0% |
2018 Q2 | 704.48 Million EUR | 0.0% |
2017 Q2 | 709.11 Million EUR | 0.0% |
2017 FY | 723.27 Million EUR | 8.21% |
2017 Q4 | 723.27 Million EUR | 0.0% |
2016 Q4 | 668.41 Million EUR | 0.0% |
2016 FY | 668.41 Million EUR | 5.8% |
2016 Q2 | 657 Million EUR | 0.0% |
2015 FY | 631.76 Million EUR | 8.12% |
2015 Q2 | 566.06 Million EUR | 0.0% |
2015 Q4 | 631.76 Million EUR | 0.0% |
2014 Q2 | 534.76 Million EUR | 0.0% |
2014 FY | 584.29 Million EUR | 16.36% |
2014 Q4 | 584.29 Million EUR | 0.0% |
2013 Q4 | 502.14 Million EUR | 0.0% |
2013 FY | 502.14 Million EUR | 18.45% |
2013 Q2 | 453.68 Million EUR | 0.0% |
2012 Q2 | 360.4 Million EUR | 0.0% |
2012 Q4 | 423.91 Million EUR | 0.0% |
2012 FY | 423.91 Million EUR | 22.57% |
2011 Q4 | 345.86 Million EUR | 0.0% |
2011 Q2 | 312.41 Million EUR | 0.0% |
2011 FY | 345.86 Million EUR | 28.83% |
2010 FY | 268.47 Million EUR | 6.72% |
2010 Q4 | 268.47 Million EUR | 0.0% |
2009 FY | 251.56 Million EUR | 0.0% |
2009 Q4 | 251.56 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Cegedim SA | 924.06 Million EUR | -63.098% |
Guerbet SA | 1.02 Billion EUR | -47.003% |
Nexus AG | 411.71 Million EUR | -266.062% |
Bastide Le Confort Médical SA | 647.06 Million EUR | -132.918% |
Revenio Group Oyj | 137.4 Million EUR | -996.896% |
Drägerwerk AG & Co. KGaA | 3.25 Billion EUR | 53.717% |
Sartorius Aktiengesellschaft | 9.75 Billion EUR | 84.551% |
Siemens Healthineers AG | 46.68 Billion EUR | 96.772% |
Medios AG | 594.75 Million EUR | -153.405% |
Equasens Société anonyme | 394.04 Million EUR | -282.478% |
Stratec SE | 479.53 Million EUR | -214.294% |